Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Pentamethine sulfobenzoindocyanine dyes with low net charge states and high photostability.

Dobson DE, Mahoney ER, Mach TP, LeTourneau RJ, Schmitthenner HF.

Photochem Photobiol Sci. 2020 Jan 22;19(1):56-65. doi: 10.1039/c9pp00445a.

PMID:
31825058
2.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018.

Hyde AJ, Nassabein R, AlShareef A, Armstrong D, Babak S, Berry S, Bossé D, Chen E, Colwell B, Essery C, Goel R, Goodwin R, Gray S, Hammad N, Jeyakuymar A, Jonker D, Karanicolas P, Lamond N, Letourneau R, Michael J, Patil N, Powell E, Ramjeesingh R, Saliba W, Singh R, Snow S, Stuckless T, Tadros S, Tehfé M, Thana M, Thirlwell M, Vickers M, Virik K, Welch S, Asmis T.

Curr Oncol. 2019 Oct;26(5):e665-e681. doi: 10.3747/co.26.5193. Epub 2019 Oct 1.

3.

Motor vehicle injury prevention in eight American Indian/Alaska Native communities: results from the 2010-2014 Centers for Disease Control and Prevention Tribal Motor Vehicle Injury Prevention Program.

Crump CE, Letourneau RJ, Billie H, Zhang X, West B.

Public Health. 2019 Nov;176:29-35. doi: 10.1016/j.puhe.2019.07.014. Epub 2019 Sep 18.

PMID:
31542168
4.

When a Drain is the Culprit: An Unexpected Case of Small Bowel Obstruction with Biliary Peritonitis.

Al Khaldi M, Thibeault F, Létourneau R.

Cureus. 2019 Jun 21;11(6):e4964. doi: 10.7759/cureus.4964.

5.

Testing the Nursing Quality and Safety Self-Inventory.

Letourneau RM, McCurry MK.

J Nurses Prof Dev. 2019 Sep/Oct;35(5):275-280. doi: 10.1097/NND.0000000000000556.

PMID:
31157672
6.

The Effect of Transition to Practice Programs on the Self-Assessment of Newly Licensed Registered Nurses' Confidence in Quality and Safety Competency Attainment.

Letourneau RM, McCurry MK.

Nurs Educ Perspect. 2019 May/Jun;40(3):151-156. doi: 10.1097/01.NEP.0000000000000438.

PMID:
30601450
7.

Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.

Collin Y, Paré A, Belblidia A, Létourneau R, Plasse M, Dagenais M, Turcotte S, Martel G, Roy A, Lapointe R, Vandenbroucke-Menu F.

Int J Surg. 2019 Jan;61:42-47. doi: 10.1016/j.ijsu.2018.11.029. Epub 2018 Dec 8.

PMID:
30537548
8.

Erratum to: nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial.

Tehfe M, Dowden S, Kennecke H, El-Maraghi R, Lesperance B, Couture F, Letourneau R, Liu H, Romano A.

Adv Ther. 2017 Jan;34(1):277-279. doi: 10.1007/s12325-016-0442-2. No abstract available.

9.

Child safety and booster seat use in five tribal communities, 2010-2014.

Billie H, Crump CE, Letourneau RJ, West BA.

J Safety Res. 2016 Dec;59:113-117. doi: 10.1016/j.jsr.2016.09.002. Epub 2016 Oct 11.

10.

nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial.

Tehfe M, Dowden S, Kennecke H, El-Maraghi R, Lesperance B, Couture F, Letourneau R, Liu H, Romano A.

Adv Ther. 2016 May;33(5):747-59. doi: 10.1007/s12325-016-0327-4. Epub 2016 Apr 16. Erratum in: Adv Ther. 2016 Nov 24;:.

11.

Nurse Residency Programs: An integrative Review of the Literature.

Letourneau RM, Fater KH.

Nurs Educ Perspect. 2015 Mar/Apr;36(2):96-101. doi: 10.5480/13-1229. Review.

PMID:
29194133
12.

Trigeminal nerve stimulation triggers oral mast cell activation and vascular permeability.

Alhelal MA, Palaska I, Panagiotidou S, Letourneau R, Theoharides TC.

Ann Allergy Asthma Immunol. 2014 Jan;112(1):40-5. doi: 10.1016/j.anai.2013.10.011. Epub 2013 Nov 9.

PMID:
24331392
13.

Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience.

D'Hondt M, Lapointe R, Benamira Z, Pottel H, Plasse M, Letourneau R, Roy A, Dagenais M, Vandenbroucke-Menu F.

Eur J Surg Oncol. 2013 Jun;39(6):548-53. doi: 10.1016/j.ejso.2013.02.010. Epub 2013 Mar 21.

PMID:
23522952
14.

Is intra-operative ultrasound still useful for the detection of a hepatic tumour in the era of modern pre-operative imaging?

D'Hondt M, Vandenbroucke-Menu F, Préville-Ratelle S, Turcotte S, Chagnon M, Plasse M, Létourneau R, Dagenais M, Roy A, Lapointe R.

HPB (Oxford). 2011 Sep;13(9):665-9. doi: 10.1111/j.1477-2574.2011.00349.x. Epub 2011 Jul 13.

15.

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study.

Kindler HL, Ioka T, Richel DJ, Bennouna J, Létourneau R, Okusaka T, Funakoshi A, Furuse J, Park YS, Ohkawa S, Springett GM, Wasan HS, Trask PC, Bycott P, Ricart AD, Kim S, Van Cutsem E.

Lancet Oncol. 2011 Mar;12(3):256-62. doi: 10.1016/S1470-2045(11)70004-3.

PMID:
21306953
16.

Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease.

Vickers M, Samson B, Colwell B, Cripps C, Jalink D, El-Sayed S, Chen E, Porter G, Goel R, Villeneuve J, Sundaresan S, Asselah J, Biagi J, Jonker D, Dawson L, Letourneau R, Rother M, Maroun J, Thirlwell M, Hussein M, Tehfe M, Perrin N, Michaud N, Hammad N, Champion P, Rajan R, Burkes R, Barrette S, Welch S, Yarom N, Asmis T.

Curr Oncol. 2010 Jun;17(3):70-7.

17.

Attract the best and brightest with comprehensive internships.

Letourneau RM.

Nurs Manage. 2010 Apr;41(4):12-6. doi: 10.1097/01.NUMA.0000370872.17725.20. No abstract available.

PMID:
20375671
18.

Hypertrophy of the non-embolized liver after chemotherapy.

Nafidi O, Désy D, Létourneau R, Côté J, Plasse M, Vandenbroucke F, Roy A, Dagenais M, Lapointe RW.

HPB (Oxford). 2009 Mar;11(2):103-7. doi: 10.1111/j.1477-2574.2009.00004.x.

19.

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study.

Spano JP, Chodkiewicz C, Maurel J, Wong R, Wasan H, Barone C, Létourneau R, Bajetta E, Pithavala Y, Bycott P, Trask P, Liau K, Ricart AD, Kim S, Rixe O.

Lancet. 2008 Jun 21;371(9630):2101-8. doi: 10.1016/S0140-6736(08)60661-3. Epub 2008 May 29.

PMID:
18514303
20.

Ride Safe: a child passenger safety program for American Indian/Alaska Native children.

Letourneau RJ, Crump CE, Bowling JM, Kuklinski DM, Allen CW.

Matern Child Health J. 2008 Jul;12 Suppl 1:55-63. doi: 10.1007/s10995-008-0332-6. Epub 2008 Mar 14.

PMID:
18340516
21.

Treatment of post liver transplantation bile duct stricture with self-expandable metallic stent.

Vandenbroucke F, Plasse M, Dagenais M, Lapointe R, Lêtourneau R, Roy A.

HPB (Oxford). 2006;8(3):202-5. doi: 10.1080/13651820500501800.

22.

Reuse of liver graft from a brain dead recipient.

Nafidi O, Letourneau R, Willems BE, Lapointe RW.

Clin Transplant. 2007 Nov-Dec;21(6):773-6.

PMID:
17988273
23.

[Outpatient laparoscopic cholecystectomy: a one year experience on unselected patients].

Vandenbroucke F, Létourneau R, Roy A, Dagenais M, Bellemare S, Plasse M, Lapointe R.

J Chir (Paris). 2007 May-Jun;144(3):215-8. French.

PMID:
17925714
24.

Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.

Abou-Alfa GK, Letourneau R, Harker G, Modiano M, Hurwitz H, Tchekmedyian NS, Feit K, Ackerman J, De Jager RL, Eckhardt SG, O'Reilly EM.

J Clin Oncol. 2006 Sep 20;24(27):4441-7.

PMID:
16983112
25.

Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study.

Vinet E, Perreault P, Bouchard L, Bernard D, Wassef R, Richard C, Létourneau R, Pomier-Layrargues G.

Can J Gastroenterol. 2006 Jun;20(6):401-4.

26.

Endoscopic treatment of a duodenal duplication cyst.

Vandenbroucke F, Dagenais M, Létourneau R, Lapointe R, Roy A.

Endoscopy. 2005 Jun;37(6):601. No abstract available.

PMID:
15933941
27.

Phase II study of troxacitabine in chemotherapy-naive patients with advanced cancer of the pancreas: gastrointestinal tumors.

Lapointe R, Létourneau R, Steward W, Hawkins RE, Batist G, Vincent M, Whittom R, Eatock M, Jolivet J, Moore M.

Ann Oncol. 2005 Feb;16(2):289-93.

PMID:
15668286
28.

Gastrointestinal stromal tumours: etiology, pathology and clinical management.

Blackstein ME, Dubé P, Fletcher JA, Keller OR, Knowling M, Létourneau R, Morris D, Riddell R, Rorke S, Swallow CJ; Canadian Advisory Committee on GIST.

Can J Gastroenterol. 2004 Sep;18 Suppl B:3B-8B. Review.

PMID:
15457300
29.

Pentosanpolysulfate (Elmiron) is a potent inhibitor of mast cell histamine secretion.

Chiang G, Patra P, Letourneau R, Jeudy S, Boucher W, Green M, Sant GR, Theoharides TC.

Adv Exp Med Biol. 2003;539(Pt B):713-29. No abstract available.

PMID:
15176320
30.

Interleukin-17 and the interleukin-17 family member network.

Huang SH, Frydas S, Kempuraj D, Barbacane RC, Grilli A, Boucher W, Letourneau R, Madhappan B, Papadopoulou N, Verna N, De Lutiis MA, Iezzi T, Riccioni G, Theoharides TC, Conti P.

Allergy Asthma Proc. 2004 Jan-Feb;25(1):17-21. Review.

PMID:
15055556
31.

Interleukin-17: a revisited study.

Huang SH, Frydas S, Conti P, Kempuraj D, Barbacane RC, Grilli A, Boucher W, Letourneau R, Papadopoulou N, Donelan J, Madhappan B, Theoharides TC, De Lutiis MA, Riccioni G, Sabatino G.

Int J Immunopathol Pharmacol. 2004 Jan-Apr;17(1):1-4. Review. No abstract available.

PMID:
15000860
32.

Flavones inhibit proliferation and increase mediator content in human leukemic mast cells (HMC-1).

Alexandrakis M, Letourneau R, Kempuraj D, Kandere-Grzybowska K, Huang M, Christodoulou S, Boucher W, Seretakis D, Theoharides TC.

Eur J Haematol. 2003 Dec;71(6):448-54.

PMID:
14703695
33.

Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells.

Kempuraj D, Huang M, Kandere-Grzybowska K, Basu S, Boucher W, Letourneau R, Athanassiou A, Theoharides TC.

Int Arch Allergy Immunol. 2003 Nov;132(3):231-9.

PMID:
14646384
34.

Ultrastructural evidence of brain mast cell activation without degranulation in monkey experimental allergic encephalomyelitis.

Letourneau R, Rozniecki JJ, Dimitriadou V, Theoharides TC.

J Neuroimmunol. 2003 Dec;145(1-2):18-26.

PMID:
14644027
35.

Interleukin-25 (or IL-17E): a new IL-17 family member with growth factor/inflammatory actions.

Kempuraj D, Frydas S, Conti P, Kandere- Grzybowska K, Boucher W, Letourneau R, Madhappan B, Huang SH, Sugimoto K, Papadopoulou NG, Christodoulou S, Theoharides TC.

Int J Immunopathol Pharmacol. 2003 Sep-Dec;16(3):185-8. Review. No abstract available.

PMID:
14611719
36.

IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells.

Kandere-Grzybowska K, Letourneau R, Kempuraj D, Donelan J, Poplawski S, Boucher W, Athanassiou A, Theoharides TC.

J Immunol. 2003 Nov 1;171(9):4830-6.

37.

IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26.

Conti P, Kempuraj D, Frydas S, Kandere K, Boucher W, Letourneau R, Madhappan B, Sagimoto K, Christodoulou S, Theoharides TC.

Immunol Lett. 2003 Sep 8;88(3):171-4. Review.

PMID:
12941475
38.

Interleukin-19 (IL-19) network revisited.

Kempuraj D, Frydas S, Kandere K, Madhappan B, Letourneau R, Christodoulou S, Boucher W, Riccioni G, Conti P, Theoharides TC.

Int J Immunopathol Pharmacol. 2003 May-Aug;16(2):95-7. Review. No abstract available.

PMID:
12797898
39.

Corticotropin-releasing factor (CRF) can directly affect brain microvessel endothelial cells.

Esposito P, Basu S, Letourneau R, Jacobson S, Theoharides TC.

Brain Res. 2003 Apr 11;968(2):192-8.

PMID:
12663088
40.

IL-10, an inflammatory/inhibitory cytokine, but not always.

Conti P, Kempuraj D, Kandere K, Di Gioacchino M, Barbacane RC, Castellani ML, Felaco M, Boucher W, Letourneau R, Theoharides TC.

Immunol Lett. 2003 Apr 3;86(2):123-9. Review.

PMID:
12644313
41.

Mechanism by which IL-16 generated by mast cells mediates allergic inflammation.

Conti P, Kempuraj D, Boucher W, Letourneau R, Theoharides TC.

Int J Immunopathol Pharmacol. 2001 Jan-Apr;14(1):1-4. No abstract available.

PMID:
12622882
42.

Inhibitory effect of retinoic acid on proliferation, maturation and tryptase level in human leukemic mast cells (HMC-1).

Alexandrakis MG, Kyriakou DS, Seretakis D, Boucher W, Letourneau R, Kempuraj D, Theoharides TC.

Int J Immunopathol Pharmacol. 2003 Jan-Apr;16(1):43-7.

PMID:
12578730
43.

Interleukin-6 and mast cells.

Conti P, Kempuraj D, Di Gioacchino M, Boucher W, Letourneau R, Kandere K, Barbacane RC, Reale M, Felaco M, Frydas S, Theoharides TC.

Allergy Asthma Proc. 2002 Sep-Oct;23(5):331-5.

PMID:
12476543
44.

Cure of gastric antral vascular ectasia by liver transplantation despite persistent portal hypertension: a clue for pathogenesis.

Vincent C, Pomier-Layrargues G, Dagenais M, Lapointe R, Létourneau R, Roy A, Paré P, Huet PM.

Liver Transpl. 2002 Aug;8(8):717-20.

45.

Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in Apolipoprotein E knockout mice.

Huang M, Pang X, Letourneau R, Boucher W, Theoharides TC.

Cardiovasc Res. 2002 Jul;55(1):150-60.

PMID:
12062718
46.

Azelastine is more potent than olopatadine n inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells.

Kempuraj D, Huang M, Kandere K, Boucher W, Letourneau R, Jeudy S, Fitzgerald K, Spear K, Athanasiou A, Theoharides TC.

Ann Allergy Asthma Immunol. 2002 May;88(5):501-6.

PMID:
12027072
47.

Interleukin-16 network in inflammation and allergy.

Conti P, Kempuraj D, Kandere K, Di Gioacchino M, Reale M, Barbacane RC, Castellani ML, Mortari U, Boucher W, Letourneau R, Theoharides TC.

Allergy Asthma Proc. 2002 Mar-Apr;23(2):103-8. Review.

PMID:
12001788
48.

Azelastine's inhibition of histamine and tryptase release from human umbilical cord blood-derived cultured mast cells as well as rat skin mast cell-induced vascular permeability: comparison with olopatadine.

Lytinas M, Kempuraj D, Huang M, Kandere K, Boucher W, Letourneau R, Jeudy S, Fitzgerald K, Spear K, Athanasiou A, Theoharides TC.

Allergy Asthma Proc. 2002 Jan-Feb;23(1):45-51.

PMID:
11894734
49.

Helical CT with CT angiography in assessing periampullary neoplasms: identification of vascular invasion.

Lepanto L, Arzoumanian Y, Gianfelice D, Perreault P, Dagenais M, Lapointe R, Létourneau R, Roy A.

Radiology. 2002 Feb;222(2):347-52.

PMID:
11818598
50.

Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress.

Boucher WS, Letourneau R, Huang M, Kempuraj D, Green M, Sant GR, Theoharides TC.

J Urol. 2002 Jan;167(1):380-4.

PMID:
11743360

Supplemental Content

Loading ...
Support Center